Genetic Polymorphism in CYP2D6 and its Association with the Safety and Efficacy of Fluvoxamine in Patients with Major Depressive Disorder . Precis. Med. Com. [Internet]. 2023 Jun. 30 [cited 2026 May 8];3(1):43-9. Available from: https://rootspress.org/journals/index.php/PMC/article/view/301